-
Study aim
-
To compare the effect of removing Hemovac drains 24 hours versus 48 hours after lower limb orthopedic surgeries on drain microbial contamination, microbial diversity, surgical site infection, hematoma, wound dehiscence, pain severity, length of hospital stay, and overall clinical outcomes of patients.
-
Design
-
Clinical trial with control group and intervention group, with parallel groups, single-blind on 180 people. Completely randomized block method for randomization
-
Settings and conduct
-
This randomized, single-blind clinical trial (blind assessor) will be conducted on orthopedic patients at Imam Khomeini Hospital in Sari. Patients will be randomly divided into two groups: removal of the Hemovac drain within 24 hours or 48 hours after surgery. At the time of drain removal, the last 5 cm of the drain will be cut sterilely and sent to the laboratory for microbial culture and antibiogram. Microbial contamination, bacterial species, and clinical complications (infection, hematoma, wound dehiscence, pain, length of stay, and antibiotic change) will be compared between the two groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Type of surgery, age over 18 years, all patients with drains with closed lower limb orthopedic surgery with internal fixation, considering the patient's BMI. Exclusion criteria: Inability to remove the drain in patients with persistent discharge, active infection before surgery, changing the drain site or disrupting its function, patient's lack of cooperation in post-operative follow-up
-
Intervention groups
-
In the intervention group, the drain will be removed after 24 hours, and in the control group, the hemovag drain will be removed after 48 hours.
-
Main outcome variables
-
Microbial contamination of the Hemovac drain tip